Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jul;56(7):1351-62.
doi: 10.1194/jlr.P058032. Epub 2015 May 25.

PLTP activity inversely correlates with CAAD: effects of PON1 enzyme activity and genetic variants on PLTP activity

Daniel Seung Kim  1 , Amber A Burt  2 , Jane E Ranchalis  2 , Simona Vuletic  3 , Tomas Vaisar  4 , Wan-Fen Li  2 , Elisabeth A Rosenthal  2 , Weijiang Dong  5 , Jason F Eintracht  6 , Arno G Motulsky  7 , John D Brunzell  4 , John J Albers  3 , Clement E Furlong  7 , Gail P Jarvik  7
Affiliations

PLTP activity inversely correlates with CAAD: effects of PON1 enzyme activity and genetic variants on PLTP activity

Daniel Seung Kim et al. J Lipid Res. 2015 Jul.

Abstract

Recent studies have failed to demonstrate a causal cardioprotective effect of HDL cholesterol levels, shifting focus to the functional aspects of HDL. Phospholipid transfer protein (PLTP) is an HDL-associated protein involved in reverse cholesterol transport. This study sought to determine the genetic and nongenetic predictors of plasma PLTP activity (PLTPa), and separately, to determine whether PLTPa predicted carotid artery disease (CAAD). PLTPa was measured in 1,115 European ancestry participants from a case-control study of CAAD. A multivariate logistic regression model was used to elucidate the relationship between PLTPa and CAAD. Separately, a stepwise linear regression determined the nongenetic clinical and laboratory characteristics that best predicted PLTPa. A final stepwise regression considering both nongenetic and genetic variables identified the combination of covariates that explained maximal PLTPa variance. PLTPa was significantly associated with CAAD (7.90 × 10(-9)), with a 9% decrease in odds of CAAD per 1 unit increase in PLTPa (odds ratio = 0.91). Triglyceride levels (P = 0.0042), diabetes (P = 7.28 × 10(-5)), paraoxonase 1 (PON1) activity (P = 0.019), statin use (P = 0.026), PLTP SNP rs4810479 (P = 6.38 × 10(-7)), and PCIF1 SNP rs181914932 (P = 0.041) were all significantly associated with PLTPa. PLTPa is significantly inversely correlated with CAAD. Furthermore, we report a novel association between PLTPa and PON1 activity, a known predictor of CAAD.

Keywords: coronary artery disease; paraoxonase 1; phospholipid transfer protein.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Correlation between PLTPa measurements from the gold-standard radiometric liposome assay used in the current study and the widely used commercial fluorometric liposome assay. The black line represents the correlation coefficient from a classical linear regression model between the two PLTPa assays.
Fig. 2.
Fig. 2.
OR association with CAAD status of PLTPa and predictors from multivariate logistic regression (n = 1,056). *0.05 > P > 0.001. **P < 0.001. See supplementary Table 4 for full regression model coefficients.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

  • Concentration of Smaller High-Density Lipoprotein Particle (HDL-P) Is Inversely Correlated With Carotid Intima Media Thickening After Confounder Adjustment: The Multi Ethnic Study of Atherosclerosis (MESA).
    Kim DS, Li YK, Bell GA, Burt AA, Vaisar T, Hutchins PM, Furlong CE, Otvos JD, Polak JF, Arnan MK, Kaufman JD, McClelland RL, Longstreth WT Jr, Jarvik GP. Kim DS, et al. J Am Heart Assoc. 2016 May 20;5(5):e002977. doi: 10.1161/JAHA.115.002977. J Am Heart Assoc. 2016. PMID: 27207961 Free PMC article.
  • Fine-mapping of lipid regions in global populations discovers ethnic-specific signals and refines previously identified lipid loci.
    Zubair N, Graff M, Luis Ambite J, Bush WS, Kichaev G, Lu Y, Manichaikul A, Sheu WH, Absher D, Assimes TL, Bielinski SJ, Bottinger EP, Buzkova P, Chuang LM, Chung RH, Cochran B, Dumitrescu L, Gottesman O, Haessler JW, Haiman C, Heiss G, Hsiung CA, Hung YJ, Hwu CM, Juang JJ, Le Marchand L, Lee IT, Lee WJ, Lin LA, Lin D, Lin SY, Mackey RH, Martin LW, Pasaniuc B, Peters U, Predazzi I, Quertermous T, Reiner AP, Robinson J, Rotter JI, Ryckman KK, Schreiner PJ, Stahl E, Tao R, Tsai MY, Waite LL, Wang TD, Buyske S, Ida Chen YD, Cheng I, Crawford DC, Loos RJF, Rich SS, Fornage M, North KE, Kooperberg C, Carty CL. Zubair N, et al. Hum Mol Genet. 2016 Dec 15;25(24):5500-5512. doi: 10.1093/hmg/ddw358. Hum Mol Genet. 2016. PMID: 28426890 Free PMC article.
  • Meta-Analysis of Genome-Wide Association Studies for Abdominal Aortic Aneurysm Identifies Four New Disease-Specific Risk Loci.
    Jones GT, Tromp G, Kuivaniemi H, Gretarsdottir S, Baas AF, Giusti B, Strauss E, Van't Hof FN, Webb TR, Erdman R, Ritchie MD, Elmore JR, Verma A, Pendergrass S, Kullo IJ, Ye Z, Peissig PL, Gottesman O, Verma SS, Malinowski J, Rasmussen-Torvik LJ, Borthwick KM, Smelser DT, Crosslin DR, de Andrade M, Ryer EJ, McCarty CA, Böttinger EP, Pacheco JA, Crawford DC, Carrell DS, Gerhard GS, Franklin DP, Carey DJ, Phillips VL, Williams MJ, Wei W, Blair R, Hill AA, Vasudevan TM, Lewis DR, Thomson IA, Krysa J, Hill GB, Roake J, Merriman TR, Oszkinis G, Galora S, Saracini C, Abbate R, Pulli R, Pratesi C, Saratzis A, Verissimo AR, Bumpstead S, Badger SA, Clough RE, Cockerill G, Hafez H, Scott DJ, Futers TS, Romaine SP, Bridge K, Griffin KJ, Bailey MA, Smith A, Thompson MM, van Bockxmeer FM, Matthiasson SE, Thorleifsson G, Thorsteinsdottir U, Blankensteijn JD, Teijink JA, Wijmenga C, de Graaf J, Kiemeney LA, Lindholt JS, Hughes A, Bradley DT, Stirrups K, Golledge J, Norman PE, Powell JT, Humphries SE, Hamby SE, Goodall AH, Nelson CP, Sakalihasan N, Courtois A, Ferrell RE, Eriksson P, Folkersen L, Franco-Cereceda A, Eicher JD, Johnson AD, Betsholtz C, Ruusalepp A, Franzén O, Schadt EE, Björkegren J… See abstract for full author list ➔ Jones GT, et al. Circ Res. 2017 Jan 20;120(2):341-353. doi: 10.1161/CIRCRESAHA.116.308765. Epub 2016 Nov 29. Circ Res. 2017. PMID: 27899403 Free PMC article.
  • Overexpression and deletion of phospholipid transfer protein reduce HDL mass and cholesterol efflux capacity but not macrophage reverse cholesterol transport.
    Kuwano T, Bi X, Cipollari E, Yasuda T, Lagor WR, Szapary HJ, Tohyama J, Millar JS, Billheimer JT, Lyssenko NN, Rader DJ. Kuwano T, et al. J Lipid Res. 2017 Apr;58(4):731-741. doi: 10.1194/jlr.M074625. Epub 2017 Jan 30. J Lipid Res. 2017. PMID: 28137768 Free PMC article.
  • Paraoxonase 1 and atherosclerosis.
    Durrington PN, Bashir B, Soran H. Durrington PN, et al. Front Cardiovasc Med. 2023 Feb 16;10:1065967. doi: 10.3389/fcvm.2023.1065967. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 36873390 Free PMC article. Review.
See all "Cited by" articles

References

    1. Rosenson R. S. 2005. Low HDL-C: a secondary target of dyslipidemia therapy. Am. J. Med. 118: 1067–1077. - PubMed
    1. Castelli W. P. 1983. Cardiovascular disease and multifactorial risk: challenge of the 1980s. Am. Heart J. 106: 1191–1200. - PubMed
    1. Acharjee S., Boden W. E., Hartigan P. M., Teo K. K., Maron D. J., Sedlis S. P., Kostuk W., Spertus J. A., Dada M., Chaitman B. R., et al. 2013. Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: a post-hoc analysis from the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation). J. Am. Coll. Cardiol. 62: 1826–1833. - PMC - PubMed
    1. Boden W. E., Probstfield J. L., Anderson T., Chaitman B. R., Desvignes-Nickens P., Koprowicz K., McBride R., Teo K., Weintraub W.; AIM-HIGH Investigators. 2011. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N. Engl. J. Med. 365: 2255–2267. - PubMed
    1. Voight B. F., Peloso G. M., Orho-Melander M., Frikke-Schmidt R., Barbalic M., Jensen M. K., Hindy G., Hólm H., Ding E. L., Johnson T., et al. 2012. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet. 380: 572–580. - PMC - PubMed

Publication types